1Hill PA,Dwyer KM,Power DA.Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy.Lupus,2000,9:458-463.
2Ripamonti C,Panzeri C,Groff L,et al.The role of somatostatin and octreotide in bowel obstruction:pre-clinical and clinical results.Tumori,2001,87:1-9.
5Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mor- tality in systemic sclerosis: results from the nationwide inpatient sample. Rheumatology ( oxford ), 2007,46 ( 12 ) : 1808 - 1813.
6A rnett FC, Willerson JT. Connective tissue diseases and the heart.//Willerson JT, Cohn JN, Wellens HJJ, et al. Cardiovascular medicine ,3rded. London : Springer,2007:2332 - 2336.
7Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortal- ity pattern of systemic lupus erythematosus. Am J Med, 1976,60 (2) :221 -225.
8Ayoub S, Hickey M J, Morand EF. Mechanisis of disease : macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol,2008 ,d(2) :98 - 105.
9Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol, 1992, 20 : 1127 - 1134.
10Hahn BH, Grossman J, Chen W, et al. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases:roles of inflamma- tion and dyslipidemia. J Autoimmun,2007,28, (2) :69 -75.
